Study With Glofitamab in Patients With MCL and Inadequate Response or Relapse Following CAR T-cell Therapy
Fondazione Italiana Linfomi - ETS
Fondazione Italiana Linfomi - ETS
National Institutes of Health Clinical Center (CC)
Canadian Cancer Trials Group
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Ascentage Pharma Group Inc.
Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud - IDCBIS